Assesses safety concerns of e-cigarettes in consumers, implying regulatory impacts on nicotine products.
The FDA intends to regulate e-cigarettes as tobacco products, since the courts blocked it from treating them as drug-delivery devices. Until the FDA asserts its new authority over tobacco, concentrated nicotine products may be sold to consumers, raising safety concerns.
No takes yet. Share an insight, caveat, or question.
Cobb et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: